Brazil approves first generic for Ozympic
Novo Nordisk is facing pressure from a new local competitor offering products at prices 30% lower, which is affecting the company's profits.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Ready to play
Ready to play
Novo Nordisk is facing pressure from a new local competitor offering products at prices 30% lower, which is affecting the company's profits.
Notice: This Is an AI-Generated Summary
Comments (0)